C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer. [electronic resource]
Producer: 20190702Description: 5780-5793 p. digitalISSN:- 1476-5594
- Cell Line, Tumor
- Cell Movement
- Cell Survival -- drug effects
- ErbB Receptors -- genetics
- Female
- Galactosyltransferases -- antagonists & inhibitors
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Glycosylation -- drug effects
- Head and Neck Neoplasms -- diagnosis
- Humans
- Itraconazole -- chemistry
- Male
- Molecular Docking Simulation
- Neoplasm Invasiveness
- Neoplasm Proteins -- antagonists & inhibitors
- Predictive Value of Tests
- Prognosis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.